K2 Therapeutics
K2 Therapeutics creates advanced antibody-based therapies focused on difficult multi-pass membrane targets to address unmet disease needs.
$50M Seed ·
Source: TNGlobal
Funding history ↓Signals
Website registeredJan 16, 2019 (7 years old)
Funding rounds
Timeline
- Website created
Companies like K2 Therapeutics
OOna Therapeutics$86.6M Series B+ · Oct 2026
AAdcytherixSeries A · Oct 2025
AAbcuro$66M Series B+ · Aug 2026
MMirador Therapeutics$250M Series B+ · Jan 2026
TTriveni$65M Series B+ · Jun 2026AArnatar Therapeutics$50M Series A · Mar 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/k2-therapeutics (get a free API key).